Neither has completed comprehensive Phase 3 safety trials for tissue healing, so long-term human safety data remains limited for both
Should GEP-44 continue producing favorable results through clinical development, the company could emerge as an attractive acquisition, licensing or partnership candidate within the fast-expanding GLP ecosystem

Folligen Therapy Shampoo: Water, sodium laureth sulfate, hydrolyzed soy protein, cocamidopropyl betain, NaC14-16 olefin sulfonate, PEG-3, phenoxyethanol, polyquaternium-7, cationic guar gum, butylene glycol, fragrance (lavender & chamomile), lauramide MEA, dl-panthenol, cupric chloride, leucine, vitamin E TPGS (tocophersolan), polysorbate 80, extracts of the following (calendula officinalis flower, hydrastis canadensis (golden seal) root, humulus lupulus (hops), equisetum arvense (horsetail), matricaria (chamomile), prunus serotina (wild cherry) and lawsonia inermis (henna) MATERIAL SAFETY DATA SHEET: Folligen Shampoo Folligen Therapy Conditioner: Water, hydrolyzed soy protein, squalane, olive oil, PEG100 stearate, behentrimonium methosulfate & cetearyl alcohol, cetyl alcohol, carthamus tinctorius seed (safflower) oil, phenoxyethanol, cetrimonium chloride, dl-panthenol, polyquaternium-7, glycerin, cationic guar gum, butylene glycol, serenoa serrulata fruit extract, polysorbate 20, fragrance (Aloe), allantoin, leucine, cupric chloride, vitamin E TPGS (tocophersolan), aloe barbadensis (aloe vera) powder, extracts of the following lawsonia inermis (henna), (calendula officinalis flower, hydrastis canadensis (golden seal) root, humulus lupulus (hops), equisetum arvense (horsetail), matricaria (chamomile) and prunus serotina (wild cherry) bark) MATERIAL SAFETY DATA SHEET: Folligen Conditioner *NOTE: Hydrolyzed soy protein used in this product is non-GMO

Dragonfly Eyes A dragonfly's compound eye consists of thousands of tiny lenses packed together
Health Conditions Existing Health Conditions : Some medications are better suited for individuals with specific health conditions